Scientific publications

Frontiers in Cardiovascular Medicine, 2022

Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice

Kumawat A., Zegeye M., Paramel G. et al.

European Journal of Heart Failure, 2022

Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

Ferreira J., Verdonschot J., Girerd N. et al.

Atherosclerosis, 2022

Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort

Rastogi T., Girerd N., Lamiral Z. et al.

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022

CSF proteomic signature predicts progression to Alzheimer's disease dementia

Vromen E., del Campo Milán M., Scheltens P. et al.

International Journal of Molecular Sciences, 2022

COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19

Costanzo M., Caterino M., Fedele R. et al.

British Journal of Dermatology, 2022

Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Navrazhina K., Frew J., Grand D. et al.

Brain, 2022

Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity

Ruck T., Barman S., Schulte-Mecklenbeck A. et al.

Inflammation, 2022

MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients

Gorreja F., Caër C., Rush S. et al.

Scientific Reports, 2022

Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)

Klimczak-Tomaniak D., de Bakker M., Bouwens E. et al.

Nature Communications, 2022

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Al-Nesf M., Abdesselem H., Bensmail I. et al.

Life, 2022

Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy

Johansson M., Ulfenborg B., Andersson C. et al.

Molecular Cancer, 2022

Proteomics technologies for cancer liquid biopsies

Ding Z., Wang N., Ji N. et al.

Journal of Clinical Medicine, 2022

Proteomics-Based Serum Alterations of the Human Protein Expression after Out-of-Hospital Cardiac Arrest: Pilot Study for Prognostication of Survivors vs. Non-Survivors at Day 1 after Return of Spontaneous Circulation (ROSC)

Hinkelbein J., Kolaparambil Varghese Johnson L., Kiselev N. et al.

Journal of Thrombosis and Haemostasis, 2022

Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach

Rademaker E., Doorduijn D., Kusadasi N. et al.

PLOS ONE, 2022

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study

Suhrs H., Nilsson M., Bové K. et al.

Translational Psychiatry, 2022

A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder

Göteson A., Isgren A., Sparding T. et al.

Scientific Reports, 2022

The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli

Lindblad A., Johansson C., Persson K. et al.

Journal of Viral Hepatitis, 2022

Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment

Khera T., Madsen L., Du Y. et al.

Digestive Diseases and Sciences, 2022

Breastfeeding Is Associated with Lower Likelihood of Helicobacter Pylori Colonization in Babies, Based on a Prospective USA Maternal-Infant Cohort

Shah S., Tarassishin L., Eisele C. et al.

Translational Vision Science & Technology, 2022

A Blood Protein Signature Stratifies Clinical Response to csDMARD Therapy in Pediatric Uveitis

Wennink R., Kalinina Ayuso V., Tao W. et al.